A community for people who want to remain as healthy as possible as we age.

Drugs' Breast Cancer Benefits Confirmed

(MedPage Today) Two separate meta-analyses of breast cancer treatment with two different adjuvant therapies -- aromatase inhibitors and bisphosphonates -- provide compelling evidence that each has a significant role to play in reducing recurrence rates and breast cancer mortality in postmenopausal women with early breast cancer.
Reports based on these meta-analyses, prepared by the Early Breast Cancer Trialists' Collaborative Group (EBCTCG), have been published online.
[Click the title, above, to post a comment.]

0 comments:

Post a Comment

Please do not give advice. We can best help each other by telling what works for us, not what we think someone else should do.